Newsroom

Dr. Lewis Silverman has been appointed director of the Hope and Heroes Division of Pediatric Hematology, Oncology and Stem Cell Transplantation at NewYork-Presbyterian Morgan Stanley Children’s Hospital and Columbia University Vagelos College of Physicians and Surgeons. Dr. Silverman will serve as the Hettinger Chair in the Department of Pediatrics at Columbia, as well as associate director of pediatric cancers at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian and Columbia.

“We are thrilled that Dr. Silverman has joined us at Columbia and NewYork-Presbyterian,” says Dr. Jordan Orange, physician-in-chief at NewYork-Presbyterian Morgan Stanley Children’s Hospital and chair of pediatrics at Columbia University Vagelos College of Physicians and Surgeons. “His track record of innovation and leadership will benefit our pediatric patients with cancer and our teams, who work hard every day to deliver the best possible outcomes.”

“I am honored to join the talented team at Columbia and NewYork-Presbyterian in their commitment to excellence, innovation, and expert patient care,” says Dr. Silverman. "Working together, we will continue to advance the field and improve outcomes for our patients and their families.”

Dr. Silverman was previously a professor of pediatrics at Harvard Medical School, vice chair for clinical affairs in pediatric oncology at the Dana-Farber Cancer Institute, and associate chief of pediatric oncology at Boston Children’s Hospital. For over 20 years, he has led the Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia (ALL) Consortium and had held multiple leadership roles in the NCI-funded Children’s Oncology Group, including serving as principal investigator for an international collaborative trial for children and adolescents with Philadelphia chromosome-positive ALL.

“Dr. Silverman is an internationally renowned expert in pediatric leukemias, from basic science to clinical care,” says Dr. Anil Rustgi, director of the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian and Columbia. “A skilled leader, Dr. Silverman is also a compassionate physician and educator. We look forward to bringing pediatric hematology, oncology and transplantation to the forefront of academic and clinical medicine.”

Dr. Silverman has more than 200 publications in journals including the New England Journal of Medicine, Cancer Cell, Science, Lancet, Nature Genetics, Blood, Lancet Oncology, and JAMA Oncology. He has made sustained contributions to the field of pediatric leukemia, has committed himself to continual progress for children with blood cancer through research, and is widely regarded as a leader in clinical innovation.

Dr. Silverman is a graduate of Harvard University and Harvard Medical School. He completed his pediatric residency at Boston Children’s Hospital and fellowship in pediatric hematology and oncology at Boston Children’s Hospital and the Dana-Farber Cancer Institute. He has served in many important leadership roles during his long tenure at Boston Children’s and Dana-Farber.